Axcelis Technologies (ACLS) Is Down 5.8% After Russell Index Removal Reshapes Its Passive Ownership Profile

• On 27 June 2026, Axcelis Technologies, Inc. was removed from multiple Russell value and small‑cap benchmarks, including the Russell 2000 and Russell 3000 Value indices, reflecting a shift in how the stock fits within these index methodologies.
• This cluster of index deletions can matter for investors because passive funds tracking these benchmarks may adjust their holdings, potentially influencing trading activity and liquidity around Axcelis shares.
• We’ll now examine how Axcelis’s removal from several Russell value and small‑cap benchmarks feeds into the company’s broader investment narrative.

Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.

Axcelis Technologies Investment Narrative Recap

To own Axcelis, you need to believe its ion implantation franchise can convert long term demand for silicon carbide power devices and advanced memory into durable earnings, even as near term bookings look muted. The recent removal from several Russell value and small cap benchmarks mainly affects how index funds trade the stock, and does not, by itself, change the key near term catalyst of execution on flat 2026 revenue guidance or the core risk around China exposure and export controls.

In that context, the first quarter 2026 results are especially relevant. Revenue grew modestly year over year to US$198.96 million, but net income fell to US$9.21 million, and management guided to roughly flat full year 2026 revenue. This combination of softer profitability and cautious outlook helps explain why Axcelis can move out of certain value oriented indices just as investors are watching whether product innovations like the Purion platform can reignite earnings momentum.

Yet behind the index changes, one risk investors should be aware of is how concentrated Axcelis still is in China and what happens if export controls...

Read the full narrative on Axcelis Technologies (it's free!)

Axcelis Technologies' narrative projects $960.6 million revenue and $87.9 million earnings by 2029. This requires 4.3% yearly revenue growth and an earnings decrease of $13.0 million from $100.9 million today.

Uncover how Axcelis Technologies' forecasts yield a $169.67 fair value, in line with its current price.

Exploring Other Perspectives

While index removals may worry you, the most optimistic analysts were still expecting about US$1.0 billion of revenue and US$95.3 million of earnings by 2029, which shows how differently investors can frame Axcelis’s China exposure risk and suggests these upbeat narratives might shift as the index news is fully absorbed.

Explore 6 other fair value estimates on Axcelis Technologies - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Axcelis Technologies research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Axcelis Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Axcelis Technologies' overall financial health at a glance.

Interested In Other Possibilities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 44 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com